Reaction
Hemianopia reporting signals
As of the last recalculation, Hemianopia appears in 986 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 66.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 26 | 66.8 | 67.0 |
| Acetylcysteine | 23 | 52.7 | 52.9 |
| Loperamide Hydrochloride Oral | 20 | 42.2 | 42.3 |
| Fam-Trastuzumab Deruxtecan-Nxki | 17 | 36.2 | 36.3 |
| Loperamide Hcl | 21 | 35.2 | 35.2 |
| Oseltamivir | 11 | 29.5 | 29.5 |
| Trazodone Hydrochloride | 18 | 24.7 | 24.8 |
| Aprepitant | 20 | 23.3 | 23.3 |
| Clobazam | 25 | 22.2 | 22.2 |
| Pertuzumab | 27 | 21.5 | 21.5 |
| Primidone | 10 | 20.9 | 20.9 |
| Alteplase | 13 | 18.5 | 18.5 |
| Bendamustine Hcl | 13 | 17.9 | 17.9 |
| Fondaparinux Sodium | 6 | 15.7 | 15.8 |
| Loperamide Hydrochloride And Dimethicone | 23 | 15.5 | 15.5 |
| Filgrastim | 26 | 15.0 | 15.0 |
| Levetiracetam In Sodium Chloride | 50 | 14.3 | 14.3 |
| Levetiracetam Oral | 50 | 14.3 | 14.3 |
| Levetiracetam Injection | 50 | 14.3 | 14.3 |
| Trastuzumab | 35 | 11.1 | 11.1 |
| Bortezomib | 45 | 11.1 | 11.1 |
| Darbepoetin Alfa | 26 | 10.4 | 10.4 |
| Capecitabine | 43 | 10.3 | 10.3 |
| Oseltamivir Phosphate | 11 | 9.6 | 9.6 |
| Ofatumumab | 13 | 8.4 | 8.4 |
| Temozolomide | 8 | 8.1 | 8.1 |
| Fingolimod Hcl | 32 | 8.0 | 8.0 |
| Dabigatran Etexilate Mesylate | 26 | 7.7 | 7.7 |
| Dabigatran Etexilate | 27 | 7.5 | 7.5 |
| Drospirenone And Ethinyl Estradiol | 15 | 7.3 | 7.3 |